Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
Holding CUE?
Track your performance easily

Cue Biopharma (CUE) Cash flow

581 Followers

Cue Biopharma Cash Flow

CUE's free cash flow for Q2 2024 was $-10.00M. For the 2024 fiscal year, CUE's free cash flow was decreased by $2.01M and operating cash flow was $-9.99M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -37.94M$ -39.96M$ -41.81M$ -38.84M$ -32.49M$ -30.80M
Investing Cash Flow
$ 9.94M$ 25.00M$ -24.61M$ 9.11M$ 4.46M$ 3.45M
Financing Cash Flow
$ 8.04M$ 11.86M$ 53.66M$ 19.23M$ 58.61M$ 50.79M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 179.25M$ 48.66M$ 51.76M$ 75.02M$ 75.02M$ 44.44M
Income Tax Paid Supplemental Data
-----$ 412.50K
Interest Paid Supplemental Data
$ 830.00K$ 1.00M$ 570.00K---
Issuance Of Capital Stock
--$ 22.70M$ 17.38M$ 56.68M$ 49.00M
Issuance Of Debt
--$ 14.56M---
Repayment Of Debt
--$ -141.00K---
Free Cash Flow
$ -38.01M$ -39.96M$ -41.97M$ -39.73M$ -33.09M$ -30.72M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cue Biopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis